Clinical Trials Logo

Filter by:
NCT ID: NCT05944445 Recruiting - Clinical trials for Thrombocytopenia; Drugs

The Incidence of Linezolid-induced Thrombocytopenia (LIT) in Critically Ill Patients, the Risk Factors for LIT

Start date: July 13, 2023
Phase:
Study type: Observational

- To identify the incidence of LIT among critically ill patients, as limited studies have only addressed this population. - To evaluate the impact of several factors on the incidence of LIT, the time to onset of LIT, and the time to recovery of platelets. - To study the effect of concurrent medications (enoxaparin, unfractinated heparin, piperacillin, carbapenems, tigecycline, fluconazole or voriconazole, digoxin, amiodarone, acetaminophen, tirofiban, statins, and antiepileptics) frequently used in critically ill patients on the incidence of LIT. - To investigate the impact of possible medications with an antioxidant effect on the prevention of LIT. - To assess the impact of LIT on composite end point (mortality, bleeding, and length of stay)

NCT ID: NCT05944341 Recruiting - Clinical trials for Dental Pulp Diseases

Articaine Efficiency in Pulpectomy of Children With Irreversible Pulpitis Under the Age of Four

Start date: June 1, 2023
Phase: N/A
Study type: Interventional

A two-tailed randomized controlled trial with two parallel arms is aimed to compare success proportions of the articaine and lidocaine groups in children with irreversible pulpitis under 4 years. The participants will be randomly assigned into two equal groups (82 children per group): the control group will receive lidocaine and the intervention group will receive the articaine local anesthesia. The direct observation tool FLACC was considered to assess pain severity. The behavior was assessed during pulpectomy procedures using the Frankl behavior rating scale (FBRS)

NCT ID: NCT05943704 Recruiting - Cow Milk Allergy Clinical Trials

The Frequency of Beef Allergy in Children With Cow Milk Allergy

Start date: September 2023
Phase: N/A
Study type: Interventional

This study aims to determine the frequency of allergy to beef meat in children with allergy to cow's milk by serum measurement. Also, the study aims to assess the sensitivity and specificity of beef IgE in relation to gold standardized of elimination challenge test and to assess effect of eating of cooked meat on symptoms of allergy in those proven to have either CMA alone +/- beef allergy (by serology).

NCT ID: NCT05942547 Recruiting - Clinical trials for Non Alcoholic Steatohepatitis

the Efficacy and Safety of Diosmin on Non-diabetic Patients With Non-alcoholic Steatohepatitis.

Start date: July 10, 2023
Phase: Phase 3
Study type: Interventional

This is a randomized, controlled study evaluating diosmin tablets administered daily for 3 months. The purpose of the study is to evaluate the efficacy and safety of diosmin on non-diabetic patients with non-alcoholic steatohepatitis.

NCT ID: NCT05942053 Recruiting - Clinical trials for Chronic Kidney Diseases

Role of Vitamin K2 in Chronic Kidney Disease

Start date: July 15, 2023
Phase: Phase 4
Study type: Interventional

This randomized placebo controlled double blind parallel clinical study will be conducted on 44 non-dialysis chronic kidney disease (CKD) patients (Stages 2-3b).Clinical Study Evaluating the Role of Vitamin K2 as Adjuvant Therapy to Angiotensin Converting Enzyme Inhibitor on Blood Pressure, Proteinuria and Bone Metabolism in Patients with Chronic Kidney Disease. Patients will be recruited from, Internal Medicine Department, Nephrology Unit, Alexandria Main University Hospital, Egypt. Patients with albumin-to-creatinine ratio ≥ 30 mg/g, with serum Potassium < 5 mEq/L and newly diagnosed patients with hypertension. The study duration will be 6 months. The patients will be randomized using stratified random block method into two groups. Group 1: Control group Non-dialysis chronic kidney disease (CKD) patients (Stages 2-3b). Patients will be treated with ramipril 10 mg/day and a placebo match vitamin K2 capsules once per day.The dose of ramipril may be modified according to blood pressure control. Group 2: Vitamin K2 (menaquinone-7) Non-dialysis chronic kidney disease (CKD) patients (Stages 2-3b).Patients will be treated with ramipril 10 mg/day and vitamin K2 capsules (menaquinone-7) 90 mcg/day. The dose of ramipril may be modified according to blood pressure control. Participants will be followed-up by weekly telephone calls and monthly direct meetings to assess their adherence for 6 months.

NCT ID: NCT05942027 Recruiting - Clinical trials for Chronic Kidney Diseases

Role of Coenzyme Q10 in Chronic Kidney Disease

Start date: July 15, 2023
Phase: Phase 4
Study type: Interventional

This randomized placebo controlled double blind parallel clinical study will be conducted on 44 non-dialysis chronic kidney disease (CKD) patients (Stages 2-3b).Clinical Study Evaluating the Role of Coenzyme Q10 as Adjuvant Therapy to Angiotensin Converting Enzyme Inhibitor on Blood Pressure, Proteinuria and Bone Metabolism in Patients with Chronic Kidney Disease. Patients will be recruited from, Internal Medicine Department, Nephrology Unit, Alexandria Main University Hospital, Egypt. Patients with albumin-to-creatinine ratio ≥ 30 mg/g, with serum Potassium < 5 mEq/L and newly diagnosed patients with hypertension. The study duration will be 6 months. The patients will be randomized using stratified random block method into two groups. Group 1: Control group Non-dialysis chronic kidney disease (CKD) patients (Stages 2-3b). Patients will be treated with ramipril 10 mg/day and a placebo match Coenzyme Q10 capsules once per day.The dose of ramipril may be modified according to blood pressure control. Group 2: Coenzyme Q10 Non-dialysis chronic kidney disease (CKD) patients (Stages 2-3b).Patients will be treated with ramipril 10 mg/day and Coenzyme Q10 capsules (CoQ10) 200 mg/day. The dose of ramipril may be modified according to blood pressure control. Participants will be followed-up by weekly telephone calls and monthly direct meetings to assess their adherence for 6 months.

NCT ID: NCT05941221 Recruiting - Hip Fractures Clinical Trials

Effect of Pericapsular Nerve Group (PENG) Block for Perioperative Analgesia in Geriatric Patients With Hip Fractures

Start date: March 30, 2023
Phase: N/A
Study type: Interventional

the goal of this clinical trial is to evaluate the analgesic effect of pericapsular nerve group (PENG) block in elderly patients with hip fractures undergoing hip surgery . and to evaluate its effect in reducing post operative complications .

NCT ID: NCT05941208 Recruiting - Hip Fractures Clinical Trials

Efficacy of Continuous Fascia Iliaca Block in Hip Surgery in Elderly

Start date: April 9, 2023
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to investigate the analgesic effect of ultrasound-guided Continuous fascia iliaca block in very elderly patients with hip fracture after hip surgery compared to systemic analgesia . The main question[s] it aims to answer are: - does continuous fascia iliaca block provide adequate post operative analgesia after hip surgery ? - does it lower the incidence of post operative complications in old age ? Participants will receive continuous fascia iliaca block through ultrasound , introducing epidural catheter 18 G , continuous infusion of bupivacaine 0.25% by a set rate of 7 ml per hour for 24 hours. Researchers will compare the study group receiving continuous fascia iliaca block to the control group receiving traditional systemic analgesia in the post operative period . to see if the analgesic effect is more effective

NCT ID: NCT05939115 Recruiting - Bipolar Depression Clinical Trials

Intensive Accelerated Theta Burst Stimulation in Treatment of Patients With Bipolar Depression and Suicidality

Start date: June 1, 2023
Phase: N/A
Study type: Interventional

The objective of this study is to compare the efficacy of left unilateral versus bilateral accelerated Theta Burst Stimulation (TBS) in suicidal reduction and in reduction of severity of depressive symptoms in patients with bipolar depression.

NCT ID: NCT05938868 Recruiting - Dental Implant Clinical Trials

Low Intensity Pulsed Ultrasound Versus Low Level Laser Therapy Post Dental Implant

Start date: July 5, 2023
Phase: N/A
Study type: Interventional

The purpose of the study is to investigate the significance difference between low intensity pulsed ultrasound (LIPUS) versus low-level laser therapy (LLLT) on osseointegration, soft tissue healing, pain pressure threshold and oral health related quality of life in patients post dental implant surgery.